相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Body Mass Index and Physical Activity at Different Ages and Risk of Multiple Myeloma in the NIH-AARP Diet and Health Study
Jonathan N. Hofmann et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Challenges of Guarantee-Time Bias
Anita Giobbie-Hurder et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
Deborah J. Kuhn et al.
BLOOD (2012)
Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells
Jingxuan Pan et al.
CELL CYCLE (2012)
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Navid Sadeghi et al.
CLINICAL CANCER RESEARCH (2012)
A Randomized Controlled Trial of an Intensive Insulin Regimen in Patients With Hyperglycemic Acute Lymphoblastic Leukemia
Khanh Vu et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2012)
Pre-existing diabetes mellitus in patients with multiple myeloma
Yi-Sheng Chou et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
X. -X. He et al.
ANNALS OF ONCOLOGY (2011)
Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies
Alice Wallin et al.
EUROPEAN JOURNAL OF CANCER (2011)
The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
Yin-Hsun Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System
Qin Huang et al.
MODERN PATHOLOGY (2011)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Novel therapeutic targets for multiple myeloma
Anuj Mahindra et al.
FUTURE ONCOLOGY (2010)
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation
A. C. Sprynski et al.
LEUKEMIA (2010)
Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma
Janne E. Reseland et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
The role of the insulin-like growth factor 1 receptor axis in multiple myeloma
Eline Menu et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Evaluating Clinical Accuracy of Continuous Glucose Monitoring Devices: Other Methods
Iris M. E. Wentholt et al.
CURRENT DIABETES REVIEWS (2008)
Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma
Wendy Cozen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Signalling and survival pathways in multiple myeloma
Kurt Bommert et al.
EUROPEAN JOURNAL OF CANCER (2006)
Type 2 diabetes mellitus, its treatment and risk for lymphoma
J Fortuny et al.
EUROPEAN JOURNAL OF CANCER (2005)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate/cytarabine regimen
MA Weiser et al.
CANCER (2004)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Mortality from site-specific malignancies in type 2 diabetic patients from Verona
G Verlato et al.
DIABETES CARE (2003)
Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
TIL Nilsen et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
